SCHEMBL18735320

SCHEMBL18735320

CCOC(=O)C(NC(=O)C(C)CC)C(C)SC(=O)CC(=O)C(=O)OC(C)C

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 8/20 0.31
▸ METAP1 P53582 6/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18735321 0.91 METAP2 (0.33) METAP2METAP1
SCHEMBL18735328 0.90 METAP2 (0.32) METAP2METAP1
SCHEMBL18735324 0.90 METAP2 (0.32) METAP2METAP1
SCHEMBL18735052 0.88 LMNA (0.32) —
SCHEMBL18735327 0.85 ACACB (0.30) —
SCHEMBL18734945 0.83 — —
SCHEMBL18735062 0.83 MGAM (0.38) METAP2METAP1
SCHEMBL18735060 0.82 KMT2A (0.31) METAP2METAP1
SCHEMBL18735334 0.81 METAP2 (0.34) METAP2METAP1
SCHEMBL18735351 0.81 METAP2 (0.31) METAP2METAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017060400-A1 PROTECTED CARBOXYLIC ACID-BASED METABOLITES FOR THE TREATMENT OF DISESASES RELATED TO MITOCHONDRIAL DYSFUNCTIONS NEUROVIVE PHARMACEUTICAL AB (SE) 2017-04-13 — — WO disclosed
Send feedback